Wall Street’s Key Stock Analysts Research Report, All Buys

#stocks #buy #bullish #risk

$NTLA $IRBT

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below are our Buy calls for Wednesday, 28 October, as follows:

Intellia Therapeutics Inc. (NASDAQ:NTLA) was started with a Buy rating and a 40 price target at Truist Securities, which noted that the 1st in-human systemically delivered CRISPR offers investors a compelling Northside story.

iRobot Corp. (NASDAQ:IRBT) said Q-3 sales soared as consumers bought products for their homes. Shares closed Tuesday at 85.18 and have a consensus price target of 82.00.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   
analystsavoidbuyhefxholdIRBTNTLAselltradeWall Street
Comments (0)
Add Comment